Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

ALIREPOTINIB
Rx
Cancer & Blood Disorders

ALIREPOTINIB

Repotrectinib
Generic (INN)
Repotrectinib
Strength
40mg
Packaging
60 capsules/bottle
Indication
Targeted treatment for ROS1-positive lung cancer and NTRK-fusion cancers. (See package insert.)
Registration No.
09 L 1388/25
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
Become a partner
EN·ລາວ·中文